Back to Trades
Astley-Sparke Philip
InsiderCIK 0001376491
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
Astley-Sparke Philip has filed 4 reports across 2 companies, totaling $887.0K in disclosed volume. Sales ($89.7K) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jun 17 | ENGN enGene Therapeutics Inc. | Astley-Sparke Philip | Insider | Other | $0 |
| May 20 | REPL Replimune Group, Inc. | Astley-Sparke Philip | Director | Sell | $89.7K |
| Apr 7 | REPL Replimune Group, Inc. | Astley-Sparke Philip | Director | Grant | $0 |
| Jul 10 | ENGN enGene Holdings Inc. | Astley-Sparke Philip | Insider | Other | $0 |
4 filings